AXGN logo

Axogen, Inc. Common Stock

AXGN

AXGN: Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

more

Show AXGN Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of AXGN by members of U.S. Congress

Politician Type Traded
Donna Shalala House / D Sale $1,001 - $15,000 Jun. 24, 2019
Donna Shalala House / D Purchase $1,001 - $15,000 Apr. 16, 2019
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by AXGN's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $10,000 Aug 07, 2023 Issue: Health Issues
  • $10,000 May 07, 2023 Issue: Health Issues
  • $10,000 Feb 09, 2023 Issue: Health Issues
  • $10,000 Nov 06, 2022 Issue: Health Issues
  • $10,000 Jul 18, 2022 Issue: Health Issues
  • $10,000 May 25, 2022 Issue: Health Issues
  • $30,000 Jan 19, 2011 Issue: Medical/Disease Research/Clinical Labs
  • $36,000 Oct 16, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $36,000 Jul 14, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $12,000 Apr 18, 2010 Issue: Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

  • Patent Title: Implant devices with a pre-set pulley system Feb. 28, 2023
  • Patent Title: Amnion tissue grafts and methods of preparing and using same Feb. 14, 2023
  • Patent Title: Wet preservation of tissue Dec. 13, 2022
  • Patent Title: Nerve culture system Nov. 29, 2022
  • Patent Title: Capture-tool for manipulating and entubulating nerves Jul. 12, 2022
  • Patent Title: Tissue grafts with pre-made attachment points Nov. 09, 2021
  • Patent Title: Organotypic drg-peripheral nerve culture system Oct. 26, 2021
  • Patent Title: Devices and methods for protecting against neuromas Oct. 19, 2021
  • Patent Title: Materials and methods for nerve repair with animal-sourced grafts Oct. 19, 2021
  • Patent Title: Materials and methods for protecting against neuromas Mar. 23, 2021
  • Patent Title: Materials and methods for protecting against neuromas Mar. 16, 2021
  • Patent Title: Implant devices with a pre-set pulley system Mar. 16, 2021
  • Patent Title: Connector and wrap for end-to-side nerve coaptation Nov. 17, 2020
  • Patent Title: Materials and methods for breast neurotization with nerve grafts Oct. 27, 2020
  • Patent Title: Quantitative structural assay of a nerve graft Sep. 22, 2020
  • Patent Title: Surgical tool for tissue sizing and transection Oct. 15, 2019
  • Patent Title: Capture-tool for manipulating and entubulating nerves Jul. 09, 2019
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 04, 2019
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 12, 2018
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 27, 2017
  • Patent Title: Materials and methods for protecting against neuromas Apr. 25, 2017
  • Patent Title: Two-point discriminator sensory measurement device Jan. 31, 2017
  • Patent Title: Nerve elevator and method of use Oct. 01, 2013
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of AXGN in WallStreetBets Daily Discussion

AXGN News

Recent insights relating to AXGN

CNBC Recommendations

Recent picks made for AXGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AXGN

Corporate Flights

Flights by private jets registered to AXGN